Literature DB >> 18160121

Identification of a ferrochelatase mutation in a Chinese family with erythropoietic protoporphyria.

Xiao-Fei Kong1, Jing Ye, De-Yong Gao, Qi-Ming Gong, Dong-Hua Zhang, Zhi-Meng Lu, Yi-Ming Lu, Xin-Xin Zhang.   

Abstract

BACKGROUND/AIMS: Erythropoietic protoporphyria (EPP) is a rare autosomal dominant disorder of heme biosynthesis characterized by a partial decrease in ferrochelatase (FECH) activity leading to excessive accumulation of protoporphyrin. While a majority of EPP patients only exhibit photosensitivity, a small percentage of patients also develop liver complications and need liver transplantation.
METHODS: In this study, we have sequenced the ferrochelatase gene of a Chinese EPP patient who suffered from EPP-related liver complications.
RESULTS: A nonsense mutation in exon 4, 343C>T, introducing a premature stop codon at position arginine 115, was identified in the proband as well as her symptomatic mother and brother, but was absent in her father. All the family members with overt photosensitivity also carried the low-expressed allele IVS3-48c, whose prevalence in the Chinese Han population was determined to be 41.35% and which was also functional in producing an aberrant 63 bp insertion.
CONCLUSION: We describe the first FECH mutation identified in the Chinese Han population and report a high frequency of the hypomorphic IVS3-48c allele in China.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18160121     DOI: 10.1016/j.jhep.2007.09.013

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  6 in total

1.  Antisense oligonucleotide-based therapy in human erythropoietic protoporphyria.

Authors:  Vincent Oustric; Hana Manceau; Sarah Ducamp; Rima Soaid; Zoubida Karim; Caroline Schmitt; Arienne Mirmiran; Katell Peoc'h; Bernard Grandchamp; Carole Beaumont; Said Lyoumi; François Moreau-Gaudry; Véronique Guyonnet-Dupérat; Hubert de Verneuil; Joëlle Marie; Herve Puy; Jean-Charles Deybach; Laurent Gouya
Journal:  Am J Hum Genet       Date:  2014-03-27       Impact factor: 11.025

Review 2.  Identification of FECH gene multiple variations in two Chinese patients with erythropoietic protoporphyria and a review.

Authors:  Zhang-Biao Long; Yong-Wei Wang; Chen Yang; Gang Liu; Ya-Li Du; Guang-Jun Nie; Yan-Zhong Chang; Bing Han
Journal:  J Zhejiang Univ Sci B       Date:  2016 Oct.       Impact factor: 3.066

Review 3.  Liver disease and erythropoietic protoporphyria: a concise review.

Authors:  María José Casanova-González; María Trapero-Marugán; E Anthony Jones; Ricardo Moreno-Otero
Journal:  World J Gastroenterol       Date:  2010-09-28       Impact factor: 5.742

4.  Novel null-allele mutations and genotype-phenotype correlation in Argentinean patients with erythropoietic protoporphyria.

Authors:  Victoria E Parera; Rita H Koole; Gardi Minderman; Annie Edixhoven; Maria V Rossetti; Alcira Batlle; Felix W M de Rooij
Journal:  Mol Med       Date:  2009-08-12       Impact factor: 6.354

5.  Biochemical and molecular diagnosis of erythropoietic protoporphyria in an Ashkenazi Jewish family.

Authors:  X Schneider-Yin; R Mamet; E I Minder; N Schoenfeld
Journal:  J Inherit Metab Dis       Date:  2008-08-31       Impact factor: 4.982

Review 6.  Iron-sulfur cluster biosynthesis and trafficking - impact on human disease conditions.

Authors:  C Wachnowsky; I Fidai; J A Cowan
Journal:  Metallomics       Date:  2018-01-24       Impact factor: 4.526

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.